Dragonfly Therapeutics

This study tested a new drug called DF9001 in 24 adults with advanced solid tumors that have not responded to other treatments. The drug works by helping the body's immune cells attack cancer cells. The main goals were to check safety and find the best dose, with some patients al…

This study tested a new drug called DF1001 in 270 adults with advanced solid tumors that have the HER2 protein. The drug works by helping the body's natural killer cells and T-cells attack cancer cells more effectively. The trial looked at safety, side effects, and how well the d…

This early-stage study tested a new drug called DF6215, alone or with another drug (pembrolizumab), in 35 adults with advanced solid tumors that could not be removed by surgery or had spread. The main goals were to find safe doses and check for side effects. This is not a cure, b…

This early-phase study tested a new drug called DF6002, alone or combined with the immunotherapy nivolumab, in 170 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see if the drugs …